BiocardiaBCDA

13F holders, Q2 2024 (June 30)
9holders
$2.97avg. 13F price*

At the end of Q2 2024, 9 institutions reported holding Biocardia Inc. (BCDA) in their 13F filings. The largest holders were Susquehanna International Group, LLP ($132K), Geode Capital Management, LLC ($39K) and Vanguard Group Inc. ($38K).

Company
Biocardia Inc.
CUSIP
09060U606
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q2 2024: 9Q2 2024Q3 2024: 9Q3 2024Q4 2024: 13Q4 2024Q1 2025: 12Q1 2025Q2 2025: 16Q2 2025Q3 2025: 18Q3 2025Q4 2025: 20Q4 2025Q1 2026: 18Q1 2026Q2 2026: 21Q2 2026

Total Exit/New Position Q2 2024

InstitutionsTotal Value
New Positions1$132K
Exits0$0

Ownership 9 holders

Susquehanna International Group, LLP 0.00% New 44,557 $132K
Geode Capital Management, LLC 0.00% Add +25.3% 13,021 $39K
Vanguard Group Inc. 0.00% Reduce -70.3% 12,884 $38K
Tower Research Capital LLC (TRC) 0.00% Add +14543.1% 3,036 $9K
Pingora Partners LLC 0.00% Reduce -0.4% 1,036 $3K
Bank of America Corp. 0.00% Add +2.0% 444 $1K
Global Retirement Partners, LLC 0.00% Reduce -0.2% 411 $1K
Morgan Stanley 0.00% No change 30 $89
Royal Bank of Canada 0.00% Add +245.1% 26 $0

"% of holder's portfolio" is BCDA's weight in each manager's 13F, not the share of Biocardia Inc. the manager owns.